We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ultrasound Helps Diagnose Lung Congestion in Dialysis Patients

By HospiMedica International staff writers
Posted on 12 Mar 2013
Asymptomatic lung congestion has been shown to increase dialysis patients’ risks of dying prematurely or experiencing myocardial infarctions or other cardiac events, according to recent research. More...
The findings also revealed that utilizing lung ultrasound to identify this congestion aids in diagnosing patients at risk. Italian investigators recently measured the degree of lung congestion in 392 dialysis patients by using a very simple and inexpensive technique—lung ultrasound.

Lung congestion due to fluid accumulation is very common among kidney failure patients on dialysis, but it frequently does not cause any symptoms. To see whether such asymptomatic congestion affects dialysis patients’ health, Carmine Zoccali, MD, from Ospedali Riuniti (Reggio Calabria, Italy) and his colleagues published their study findings February 28, 2013, in the Journal of the American Society of Nephrology (JASN).

Among the major findings (1) Lung ultrasound revealed very severe congestion in 14% of patients and moderate-to-severe lung congestion in 45% of patients. (2) Among those with moderate-to-severe lung congestion, 71% were asymptomatic. (3) Compared with those having slight or no congestion, those with very severe congestion had a 4.2-fold increased risk of dying and a 3.2-fold increased risk of experiencing heart attacks or other cardiac events over a two-year follow-up period. (4) Lastly, asymptomatic lung congestion identified by lung ultrasound was a better predictor of patients’ risk of dying prematurely or experiencing cardiac events than symptoms of heart failure.

By evaluating subclinical pulmonary edema can help better establish dialysis patients’ prognoses, according to the findings. “More importantly, our findings generate the hypothesis that targeting subclinical pulmonary congestion may improve cardiovascular health and reduce risk from cardiovascular death in the dialysis population, a population at an extremely high risk,” said Dr. Zoccali. Fluid in the lungs may be decreased with longer and/or more frequent dialysis.

The researchers will soon initiate a clinical trial that will integrate lung fluid measurements by ultrasound and will examine whether dialysis intensification in patients with asymptomatic lung congestion can reduce the risk of heart failure and cardiac events and prevent premature death.

Related Links:

Ospedali Riuniti



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.